Related Experiment Video
Updated: May 27, 2025

09:54
Laboratory Scale Production and Purification of a Therapeutic Antibody
Published on: January 24, 2017
17.3K
Exploring the Blueprint of Life: The Innovation in Antibody and Protein Design
Zhiwei Yang1, Gerald H Lushington2
1MOE Key Laboratory for Non-equilibrium Synthesis and Modulation of Condensed Matter, School of Physics, Xi'an Jiaotong University, Xi'an 710049, China.
Combinatorial Chemistry & High Throughput Screening
|February 21, 2025
Summary
Antibody and protein design now uses advanced computational methods and artificial intelligence (AI), moving beyond older techniques. Tools like AlphaFold enable accurate structure prediction, driving innovation in biomedical sciences.
Area of Science:
- Biochemistry and Molecular Biology
- Computational Biology
- Bioengineering
Background:
- The field of antibody and protein design has evolved from empirical methods to sophisticated computational strategies.
- Key principles include combinatorial, structure-based, consensus, and computational (in silico) design for predicting protein structures from sequences.
Discussion:
- Advanced tools such as AlphaFold and the Rosetta suite significantly improve the accuracy of protein structure prediction.
- Accurate structure prediction is crucial for developing novel functional proteins and antibodies.
Key Insights:
- The integration of computational methods and artificial intelligence (AI) represents a paradigm shift in protein and antibody design.
- Accurate in silico structure prediction facilitates the creation of targeted therapeutic proteins and antibodies.
Outlook:
- Future challenges include enhancing prediction accuracy, modeling protein flexibility, understanding dynamic structural behaviors, and optimizing the design of binding and catalytic sites.
- Continued advancements promise transformative applications in biomedical sciences, human health, and scientific discovery.
Keywords:
Combinatorial protein designcomputational design guided by physical principlesdata-driven developmentmachine-learning methodssequence-based (consensus) designstructure-based designMore Related Videos
Related Concept Videos
Antibody Structure
58.8K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
58.8K
Antibody Structure and Classes
735
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
735
Hybridoma Technology
14.0K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.0K
Immunoprecipitation
5.2K
Immunoprecipitation, or IP, is a widely used technique that employs protein-antibody interactions to isolate proteins or protein complexes in their native state for studying protein-protein interactions, quaternary structures, or supramolecular complexes. Various modifications of the technique, including chromatin IP, cross-linking IP, and fluorescence IP, are commonly used.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
5.2K

